Millennium Management’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.34M | Sell |
944,853
-159,059
| -14% | -$394K | ﹤0.01% | 2573 |
|
|
2025
Q1 | $1.71M | Buy |
1,103,912
+545,836
| +98% | +$846K | ﹤0.01% | 2689 |
|
|
2024
Q4 | $1.19M | Buy |
558,076
+331,331
| +146% | +$709K | ﹤0.01% | 2790 |
|
|
2024
Q3 | $986K | Sell |
226,745
-778,133
| -77% | -$3.38M | ﹤0.01% | 2930 |
|
|
2024
Q2 | $4.68M | Buy |
1,004,878
+458,641
| +84% | +$2.14M | ﹤0.01% | 1973 |
|
|
2024
Q1 | $2.77M | Buy |
546,237
+424,428
| +348% | +$2.15M | ﹤0.01% | 2394 |
|
|
2023
Q4 | $342K | Sell |
121,809
-253,942
| -68% | -$714K | ﹤0.01% | 3355 |
|
|
2023
Q3 | $1.08M | Buy |
375,751
+23,072
| +7% | +$66.2K | ﹤0.01% | 2876 |
|
|
2023
Q2 | $1.78M | Sell |
352,679
-423,915
| -55% | -$2.14M | ﹤0.01% | 2596 |
|
|
2023
Q1 | $1.47M | Buy |
776,594
+252,037
| +48% | +$476K | ﹤0.01% | 2767 |
|
|
2022
Q4 | $944K | Buy |
524,557
+177,577
| +51% | +$320K | ﹤0.01% | 3210 |
|
|
2022
Q3 | $586K | Buy |
346,980
+99,440
| +40% | +$168K | ﹤0.01% | 3727 |
|
|
2022
Q2 | $609K | Buy |
+247,540
| New | +$609K | ﹤0.01% | 3753 |
|
|
2022
Q1 | – | Sell |
-272,035
| Closed | -$1.45M | – | 5161 |
|
|
2021
Q4 | $1.45M | Buy |
272,035
+26,518
| +11% | +$141K | ﹤0.01% | 3202 |
|
|
2021
Q3 | $2.08M | Sell |
245,517
-82,641
| -25% | -$699K | ﹤0.01% | 2990 |
|
|
2021
Q2 | $4M | Buy |
328,158
+187,528
| +133% | +$2.29M | ﹤0.01% | 2386 |
|
|
2021
Q1 | $3.41M | Sell |
140,630
-32,700
| -19% | -$793K | ﹤0.01% | 2412 |
|
|
2020
Q4 | $5.56M | Buy |
173,330
+134,886
| +351% | +$4.32M | ﹤0.01% | 1827 |
|
|
2020
Q3 | $1.16K | Buy |
38,444
+24,458
| +175% | +$739 | ﹤0.01% | 2394 |
|
|
2020
Q2 | $590K | Buy |
13,986
+4,690
| +50% | +$198K | ﹤0.01% | 2650 |
|
|
2020
Q1 | $232K | Buy |
+9,296
| New | +$232K | ﹤0.01% | 2662 |
|